Sulfadiazine

ATC Code J01EC02

Sulfadiazine

Definition

A synthetic pyrimidinyl sulfonamide derivative, short-acting bacteriostatic Sulfadiazine inhibits bacterial folic acid synthesis by competing with para amino benzoic acid. It is used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections. (NCI04)

Also known as SULFADIAZINE — per NCIT

Also identified as

Indications

Disease Relation Source
Meningococcal meningitis may prevent MEDRT · Public domain (U.S. Government work)
Rheumatic fever may prevent MEDRT · Public domain (U.S. Government work)
Chancroid may treat MEDRT · Public domain (U.S. Government work)
Malaria may treat MEDRT · Public domain (U.S. Government work)
Meningococcal meningitis may treat MEDRT · Public domain (U.S. Government work)
Nocardiosis may treat MEDRT · Public domain (U.S. Government work)
Otitis media may treat MEDRT · Public domain (U.S. Government work)
Toxoplasmosis may treat MEDRT · Public domain (U.S. Government work)
Trachoma may treat MEDRT · Public domain (U.S. Government work)
Urinary tract infection may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Craniocervical region may treat a disease of this organ DERIVED · CC BY 4.0
Ear may treat a disease of this organ DERIVED · CC BY 4.0
Middle ear may treat a disease of this organ DERIVED · CC BY 4.0

3 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.